Incyte Corp
Change company Symbol lookup
Select an option...
INCY Incyte Corp
CHH Choice Hotels International Inc
CORT Corcept Therapeutics Inc
CVS CVS Health Corp
NVAX Novavax Inc
MRK Merck & Co Inc
HYT BlackRock Corporate High Yield Fund, Inc
FNMA Federal National Mortgage Association
CPKF Chesapeake Financial Shares Inc
AGNC Agnc Investment Corp
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late-stage development, and commercialized products, such as JAKAFI (ruxolitinib) and ICLUSIG (ponatinib). JAKAFI (ruxolitinib) is indicated for the treatment of patients with intermediate or high risk myelofibrosis (MF) and for the treatment of patients with polycythemia vera (PV) having had an inadequate response to or are intolerant of hydroxyurea. As of December 31, 2016, the Food and Drug Administration had granted JAKAFI orphan drug status for MF, PV and essential thrombocythemia. The primary target for ICLUSIG is B Cell Receptor-ABL, an abnormal tyrosine kinase that is expressed in chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia. The Company also has a portfolio of selective janus associated kinases 1 (JAK1) inhibitors.

Closing Price
$87.76
Day's Change
-2.87 (-3.17%)
Bid
--
Ask
--
B/A Size
--
Day's High
91.29
Day's Low
86.90
Volume
(Average)
Volume:
1,037,394

10-day average volume:
1,108,321
1,037,394
  • Prev Close
    90.63
  • Today's Open
    91.04
  • Day's Range
    86.90-91.29
  • Avg Vol (10-day)
    1.1M
  • Last (time)
    3:59p ET 10/19/20
  • Last (size)
    1
  • 52-Wk Range
    62.48 - 110.37
    LowHigh
  • (03/23/20 - 07/07/20)
    20.48%
  • 41.0%
  • Market Cap
    19.2B
  • Shares Outstanding
    218.7M
  • -0.91
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.1
  • 94.85
  • (% of float 09/30/20)
    2.29

Latest News

October 08, 2020
11:39 am ET
PR Newswire
10:29 am ET
Globe Newswire
October 05, 2020
12:48 pm ET
BusinessWire
12:00 pm ET
BusinessWire
October 03, 2020
3:09 pm ET
MarketWatch
September 21, 2020
7:30 am ET
MarketWatch
September 18, 2020
7:44 am ET
PR Newswire
6:00 am ET
BusinessWire
September 17, 2020
4:38 pm ET
Accesswire
4:03 pm ET
BusinessWire
September 14, 2020
7:48 am ET
MarketWatch
6:30 am ET
PR Newswire
September 09, 2020
10:05 am ET
BusinessWire
September 02, 2020
5:04 pm ET
BusinessWire
September 01, 2020
8:00 am ET
BusinessWire
August 18, 2020
4:25 pm ET
Accesswire
4:02 pm ET
BusinessWire
August 07, 2020
9:11 am ET
MarketWatch
August 05, 2020
8:23 am ET
MarketWatch
August 04, 2020
7:00 am ET
BusinessWire
July 31, 2020
7:51 pm ET
BusinessWire
July 23, 2020
7:15 am ET
BusinessWire
June 22, 2020
9:34 am ET
MarketWatch
June 15, 2020
7:37 am ET
MarketWatch
6:50 am ET
MarketWatch
6:49 am ET
MarketWatch
May 08, 2020
2:46 pm ET
MarketWatch
May 06, 2020
6:48 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.